Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,943 DKK | +1.04% | +0.87% | -9.28% |
05-21 | Genmab A/S Reaffirms Financial Guidance for 2024 | CI |
05-21 | Genmab A/S completed the acquisition of ProfoundBio, Inc. | CI |
Sales 2024 * | 19.8B 2.88B 3.92B | Sales 2025 * | 23.62B 3.43B 4.68B | Capitalization | 125B 18.17B 24.74B |
---|---|---|---|---|---|
Net income 2024 * | 4.67B 679M 925M | Net income 2025 * | 6.61B 962M 1.31B | EV / Sales 2024 * | 5 x |
Net cash position 2024 * | 25.9B 3.77B 5.13B | Net cash position 2025 * | 32.35B 4.7B 6.41B | EV / Sales 2025 * | 3.92 x |
P/E ratio 2024 * |
28.5
x | P/E ratio 2025 * |
20.5
x | Employees | 2,286 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.51% |
Latest transcript on Genmab A/S
1 day | +1.04% | ||
1 week | +0.87% | ||
Current month | +0.82% | ||
1 month | -2.08% | ||
3 months | +0.83% | ||
6 months | -10.06% | ||
Current year | -9.28% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 98-12-31 | |
Anthony Pagano
DFI | Director of Finance/CFO | 46 | 06-12-31 |
Anthony Mancini
COO | Chief Operating Officer | 53 | 20-03-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Deirdre Connelly
CHM | Chairman | 63 | 16-12-31 |
Director/Board Member | 73 | 03-10-31 | |
Rolf K. Hoffmann
BRD | Director/Board Member | 64 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1,928 | +0.10% | 4,210 |
24-05-30 | 1,926 | -0.08% | 8,142 |
24-05-29 | 1,927 | -0.39% | 3,237 |
24-05-28 | 1,934 | -1.04% | 4,678 |
24-05-27 | 1,955 | +1.47% | 88,839 |
Delayed Quote London S.E., May 31, 2024 at 10:55 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- GMAB Stock
- 0MGB Stock